Iris T. Chan
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Melanoma and MAPK Pathways 5
- PI3K/AKT/mTOR signaling in cancer 2
- Cell death mechanisms and regulation 2
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Luna C. Musib (4 shared papers)Koichi Akashi (1 shared paper)Leisa Johnson (1 shared paper)Tyler Jacks (1 shared paper)Ifor R. Williams (1 shared paper)D. Gary Gilliland (1 shared paper)David Arthur Tuveson (1 shared paper)Jeffery Lorne Kutok (1 shared paper)
- Journals
- Investigational New Drugs (3 papers)Journal of Clinical Investigation (1 paper)Blood (1 paper)The Lancet Oncology (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Iris T. Chan
17 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 67
- Cancer Research 166
- Hematology 157
- Molecular Biology 619
- Oncology 176
- Pulmonary and Respiratory Medicine 172
Countries citing papers authored by Iris T. Chan
This map shows the geographic impact of Iris T. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris T. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris T. Chan more than expected).
Fields of papers citing papers by Iris T. Chan
This network shows the impact of papers produced by Iris T. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris T. Chan. The network helps show where Iris T. Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris T. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 256 | |
| 2 | 2014 | 227 | |
| 3 | 2004 | 221 | |
| 4 | 2012 | 211 | |
| 5 | 2019 | 83 | |
| 6 | 2016 | 72 | |
| 7 | 1993 | 60 | |
| 8 | 2006 | 47 | |
| 9 | 2018 | 47 | |
| 10 | 2013 | 36 | |
| 11 | 2019 | 30 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 27 | |
| 14 | 2012 | 18 | |
| 15 | 2022 | 17 | |
| 16 | 2012 | 14 | |
| 17 | 2002 | 1 | |
| 18 | 2021 | 0 |
About Iris T. Chan
Iris T. Chan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Hematology, Immunology and Biochemistry, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Advanced Breast Cancer Therapies (4 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cell death mechanisms and regulation (2 papers), Drug Transport and Resistance Mechanisms (1 paper), Antifungal resistance and susceptibility (1 paper), Drug Solubulity and Delivery Systems (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Cancer Research (166 citations), Hematology (157 citations), Molecular Biology (619 citations), Oncology (176 citations) and Pulmonary and Respiratory Medicine (172 citations). Iris T. Chan has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Luna C. Musib, Koichi Akashi, Leisa Johnson, Tyler Jacks, Ifor R. Williams, D. Gary Gilliland, David Arthur Tuveson, Jeffery Lorne Kutok, Hirokazu Shigematsu and Jill M. Spoerke. Their work appears in journals such as Investigational New Drugs, Journal of Clinical Investigation, Blood, The Lancet Oncology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.